SureTrader
Home > Boards > US Listed > Medical - Equipment > Navidea Biopharmaceuticals, Inc. (NAVB)

The old timers on IV sometimes have rose

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
sts66 Member Profile
 
Followed By 30
Posts 4,833
Boards Moderated 0
Alias Born 04/26/10
160x600 placeholder
Advertisement
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 7/6/2015 4:12:34 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/6/2015 12:27:50 PM
Navidea Biopharmaceuticals and Macrophage Therapeutics to Host Post-International KSHV Conference Summary Webcast "Business Wire" - 7/2/2015 6:12:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/2/2015 4:08:09 PM
Macrophage Therapeutics Reports Data Demonstrating a Manocept™ Drug Conjugate Induces Apoptosis in CD206 Positive Kaposi’... "Business Wire" - 7/2/2015 7:45:00 AM
Navidea Reports Clinical Data Demonstrating Manocept™ Agent Localizes in Multiple KS Lesions "Business Wire" - 7/2/2015 7:30:00 AM
3 Biotech Stocks with Low Liquidity Ratios -- Are They in Trouble? "The Motley Fool" - 6/29/2015 9:03:02 AM
Navidea Biopharmaceuticals to Present at JMP Life Sciences Conference "Business Wire" - 6/17/2015 9:11:00 AM
Macrophage Therapeutics to Present at BIO2015 Conference "Business Wire" - 6/15/2015 7:30:00 AM
BIND Therapeutics & Macrophage Therapeutics Announce Collaboration to Engineer CD206 Targeted Accurin™ Nanoparticle Using M... "Business Wire" - 6/11/2015 8:00:00 AM
Navidea Reports Manocept™ Study Results in Rheumatoid Arthritis Presented at EULAR 2015 European Congress of Rheumatology "Business Wire" - 6/11/2015 7:30:00 AM
Navidea Reports Positive Lymphoseek® Comparative Results in Injection Site Pain Study in Breast Cancer "Business Wire" - 6/8/2015 4:30:00 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 6/5/2015 11:46:55 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/4/2015 4:09:48 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 6/4/2015 3:13:42 PM
Navidea to Report Manocept™ Results in Kaposi’s Sarcoma at the International Workshop on KSHV and Related Agents "Business Wire" - 6/4/2015 12:51:00 PM
Navidea Biopharmaceuticals Appoints Anton Gueth to Board of Directors "Business Wire" - 6/4/2015 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/2/2015 4:52:15 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/1/2015 12:36:12 PM
Amended Statement of Changes in Beneficial Ownership (4/a) "Edgar (US Regulatory)" - 6/1/2015 12:31:39 PM
Specialized Disclosure Report (sd) "Edgar (US Regulatory)" - 5/29/2015 11:15:20 AM
Navidea Biopharmaceuticals to Present at Jefferies Global Healthcare Conference "Business Wire" - 5/26/2015 12:25:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/26/2015 10:18:01 AM
Amended Current Report Filing (8-k/a) "Edgar (US Regulatory)" - 5/21/2015 4:33:08 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/15/2015 4:14:45 PM
sts66   Wednesday, 04/24/13 08:06:49 PM
Re: hondadriver1973 post# 3569
Post # of 7982 
The old timers on IV sometimes have rose colored glasses on....they refuse to see manipulation.....being shorted by firms supposedly investing in NAVB....even the words "basher" or similar are not allowed by DDB....this just doesn't smell right to me.....and JPM apparently bought some for a 2nd unnamed investor again, same thing as last time....who are these mystery buyers and why are their names being kept a secret?

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist